Merck Moves to Dismiss Vioxx Suit, Says Plaintiff Produced False Evidence at Deposition



DOCUMENTS
  • Motion


ASHLAND, Ala. - Merck & Co. Inc. has moved for summary judgment and asked an Alabama court to dismiss what is expected to be the first Vioxx case to go to trial in the nation, alleging that the plaintiff's claims that the arthritis drug caused her husband's death were based on a 'bogus' set of circumstances. Rogers v. Merck & Co., Inc., No. CV-03-073 (Ala. Cir. Ct., Clay Cty.).

In a motion filed April 12, Merck suggests that Plaintiff Cheryl Rogers fabricated the sequence of events leading up to the alleged Vioxx-related death of her husband Mark, and committed fraud …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference

March 26, 2025 - Charlotte, NC
Omni Charlotte Hotel

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

April 08, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS